| RS2504151015 |
NBEA
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2504151276 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS2504151460 |
TRPM1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS2504153232 |
GABRB3
|
Health Risk |
Pathogenic |
Epilepsy, childhood absence |
| RS2504153506 |
GABRB3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 43 |
| RS2504153682 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epilepsy, childhood absence |
| RS2504164846 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504169004 |
VRK1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504169446 |
VRK1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504172140 |
GABRB3
|
Health Risk |
Pathogenic |
Epilepsy, childhood absence |
| RS2504172418 |
GABRB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, Epilepsy |
| RS2504175252 |
MAX
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2504175858 |
ACTC1
|
Health Risk |
Likely pathogenic |
Arthrogryposis, Arthrogryposis |
| RS2504176178 |
MAX
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2504176263 |
MAX
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS2504177349 |
ACTC1
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 11, Atrial septal defect 5 |
| RS2504180886 |
ACTC1
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 11, Dilated cardiomyopathy 1R |
| RS2504184408 |
VRK1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504185136 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504185145 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504185348 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504185954 |
ZMYM2
|
Health Risk |
Likely pathogenic |
ZMYM2-related disorder, ZMYM2-related disorder |
| RS2504189182 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS2504191241 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504194332 |
VRK1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504194635 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504194954 |
VRK1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504196890 |
ZMYM2
|
Health Risk |
Pathogenic |
— |
| RS2504196928 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504197072 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504197333 |
MAX
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2504197609 |
ZMYM2
|
Health Risk |
Pathogenic |
— |
| RS2504199587 |
MAX
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2504200802 |
MAX
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2504201797 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Li-Fraumeni syndrome 1 |
| RS2504201839 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Li-Fraumeni syndrome 1 |
| RS2504205415 |
GABRB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, childhood absence |
| RS2504205459 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epilepsy, childhood absence |
| RS2504209855 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504210003 |
TRPM1
|
Health Risk |
Likely pathogenic |
— |
| RS2504210475 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504213280 |
GABRB3
|
Health Risk |
Likely pathogenic |
— |
| RS2504213487 |
GABRB3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 43 |
| RS2504213556 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epilepsy, childhood absence |
| RS2504215456 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS2504215863 |
TTLL5
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 19, Cone-rod dystrophy 19 |
| RS2504221771 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2504230996 |
TRPM1
|
Health Risk |
Likely pathogenic |
— |
| RS2504231588 |
INF2
|
Health Risk |
Pathogenic |
— |
| RS2504232979 |
INF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease dominant intermediate E, Charcot-Marie-Tooth disease dominant intermediate E |
| RS2504233229 |
INF2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 5, Focal segmental glomerulosclerosis 5 |
| RS2504237386 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2504238331 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2504241662 |
INF2
|
Health Risk |
Likely pathogenic |
Kidney disorder, Kidney disorder |
| RS2504243195 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS2504243379 |
INF2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 5, Focal segmental glomerulosclerosis 5 |
| RS2504245792 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2504246108 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2504247119 |
INF2
|
Health Risk |
Likely pathogenic |
INF2-related disorder, INF2-related disorder |
| RS2504250471 |
MEIS2
|
Health Risk |
Likely pathogenic |
Cardiac malformation, cleft lip/palate |
| RS2504250485 |
MEIS2
|
Health Risk |
Likely pathogenic |
— |
| RS2504250511 |
MEIS2
|
Health Risk |
Pathogenic |
— |
| RS2504250536 |
MEIS2
|
Health Risk |
Likely pathogenic |
Cardiac malformation, cleft lip/palate |
| RS2504251871 |
VRK1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504252308 |
VRK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 1A, Neuronopathy |
| RS2504252312 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontoneocerebellar hypoplasia |
| RS2504252353 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2504262571 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Retinal dystrophy |
| RS2504262624 |
SPATA7
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2504271197 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2504282342 |
KNL1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2504286530 |
TTLL5
|
Health Risk |
Likely pathogenic |
TTLL5-related disorder, TTLL5-related disorder |
| RS2504297792 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2504306619 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504323828 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS2504329220 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epilepsy, childhood absence |
| RS2504330272 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epilepsy, childhood absence |
| RS2504336140 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2504336964 |
GCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2504342839 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2504343509 |
GCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2504343638 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, Dystonia 5 |
| RS2504344357 |
MDGA2
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2504387570 |
TECPR2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2504390380 |
GCH1
|
Health Risk |
Pathogenic |
— |
| RS2504404306 |
MAX
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2504405092 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504406488 |
RAD51
|
Health Risk |
Likely pathogenic |
RAD51-related disorder, RAD51-related disorder |
| RS2504407945 |
MAX
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2504410874 |
TECPR2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504410935 |
TECPR2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504411130 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504417338 |
TECPR2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504417581 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504418023 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504418131 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504423596 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504423776 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504423788 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504424733 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |